The burden of OA-health services and economics
- PMID: 34023527
- PMCID: PMC8605034
- DOI: 10.1016/j.joca.2021.05.007
The burden of OA-health services and economics
Abstract
Osteoarthritis (OA) is a highly prevalent and disabling condition that affects over 7% of people globally (528 million people). Prevalence levels are even higher in countries with established market economies, which have older demographic profiles and a higher prevalence of obesity, such as the US (14%). As the 15th highest cause of years lived with disability (YLDs) worldwide, the burden OA poses to individuals is substantial, characterized by pain, activity limitations, and reduced quality of life. The economic impact of OA, which includes direct and indirect (time) costs, is also substantial, ranging from 1 to 2.5% of gross national product (GNP) in countries with established market economies. In regions around the world, the average annual cost of OA for an individual is estimated between $700-$15,600 (2019 USD). Though trends in OA prevalence vary by geography, the prevalence of OA is projected to rise in regions with established market economies such as North America and Europe, where populations are aging and the prevalence of obesity is rising.
Keywords: Direct medical costs of osteoarthritis; Epidemiology of osteoarthritis; Health services; Indirect medical costs of osteoarthritis; Individual and societal burdens of osteoarthritis; Osteoarthritis.
Copyright © 2021 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Global burden of early-onset osteoarthritis, 1990-2019: results from the Global Burden of Disease Study 2019.Ann Rheum Dis. 2024 Jun 12;83(7):915-925. doi: 10.1136/ard-2023-225324. Ann Rheum Dis. 2024. PMID: 38429104
-
The impact of osteoarthritis on early exit from work: results from a population-based study.BMC Public Health. 2018 Apr 11;18(1):472. doi: 10.1186/s12889-018-5381-1. BMC Public Health. 2018. PMID: 29642918 Free PMC article.
-
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017.Ann Rheum Dis. 2020 Jun;79(6):819-828. doi: 10.1136/annrheumdis-2019-216515. Epub 2020 May 12. Ann Rheum Dis. 2020. PMID: 32398285
-
Economics of osteoarthritis: a global perspective.Baillieres Clin Rheumatol. 1997 Nov;11(4):817-34. doi: 10.1016/s0950-3579(97)80011-8. Baillieres Clin Rheumatol. 1997. PMID: 9429738 Review.
-
The impact of osteoarthritis in the United States: a population-health perspective.Am J Nurs. 2012 Mar;112(3 Suppl 1):S13-9. doi: 10.1097/01.NAJ.0000412646.80054.21. Am J Nurs. 2012. PMID: 22373741 Review.
Cited by
-
Trends in Arthritis Prevalence and Associated Chronic Health Indicators Among Adults: Insights From the Behavioral Risk Factor Surveillance System (BRFSS) Database.Cureus. 2024 Apr 24;16(4):e58925. doi: 10.7759/cureus.58925. eCollection 2024 Apr. Cureus. 2024. PMID: 38800280 Free PMC article.
-
Recent Trends in Adipose Tissue-Derived Injectable Therapies for Osteoarthritis: A Scoping Review of Animal Models.Medicina (Kaunas). 2024 Apr 25;60(5):707. doi: 10.3390/medicina60050707. Medicina (Kaunas). 2024. PMID: 38792890 Free PMC article. Review.
-
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis.Curr Gene Ther. 2024;24(4):331-345. doi: 10.2174/0115665232275532231213063634. Curr Gene Ther. 2024. PMID: 38783531
-
Variation in processes of care for total hip arthroplasty across high-income countries.Health Aff Sch. 2024 Apr 24;2(4):qxae043. doi: 10.1093/haschl/qxae043. eCollection 2024 Apr. Health Aff Sch. 2024. PMID: 38756170 Free PMC article.
-
Osteoarthritis patients exhibit an autonomic dysfunction with indirect sympathetic dominance.J Transl Med. 2024 May 16;22(1):467. doi: 10.1186/s12967-024-05258-9. J Transl Med. 2024. PMID: 38755685 Free PMC article.
References
-
- Global Burden of Disease Study 2019 (GBD 2019) results. Global Burden of Disease Collaborative Network 2019.
-
- What is osteoarthritis (OA)? : Centers for Disease Control and Prevention 2020.
-
- Global Burden of Disease Study 2019 (GBD 2019) results. Osteoarthritis--level 3 cause: Global Burden of Disease Collaborative Network 2020.
-
- Garstang SV, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil 2006; 85: S2–11; quiz S12–14. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials